Kunkel Lori Anne 4
4 · Oric Pharmaceuticals, Inc. · Filed Jun 4, 2024
Insider Transaction Report
Form 4
Kunkel Lori Anne
Director
Transactions
- Exercise/Conversion
Common Stock
2024-06-03$3.75/sh+20,500$76,875→ 20,500 total - Exercise/Conversion
Stock Option (right to buy)
2024-06-03−20,500→ 33,200 totalExercise: $3.75Exp: 2032-06-16→ Common Stock (20,500 underlying)
Footnotes (1)
- [F1](A) 20,500 of the shares subject to the option shall vest on the earlier of (i) June 17, 2023 or (ii) the business day prior to the next annual meeting of the Issuer's stockholders that occurs following the date of grant, and (B) one thirty-sixth (1/36th) of the remaining 33,200 shares subject to the option shall vest on each monthly anniversary of June 17, 2022.